BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//ARMI - ECPv6.16.4.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.armiusa.org
X-WR-CALDESC:Events for ARMI
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251109
DTEND;VALUE=DATE:20251113
DTSTAMP:20250609T172246Z
CREATED:20250117T180107Z
LAST-MODIFIED:20250609T172246Z
UID:10001762-1762646400-1762991999@www.armiusa.org
SUMMARY:TERMIS-AM  2025
DESCRIPTION:We are excited to announce ARMI’s active participation in the Tissue Engineering and Regenerative Medicine International Society (TERMIS-AM) 2025 Conference\, a premier event bringing together global leaders in regenerative medicine. Mark your calendars for November 9-13\, 2025\, in Atlanta\, GA\, and join us for an inspiring lineup of sessions hosted by ARMI experts and visionaries. \nOpening Plenary Symposium: \nDean Kamen\, ARMI’s Executive Director\, has been invited to speak during the Opening Plenary Symposium on Sunday\, November 9\, 2025\, from 5:30 PM – 6:30 PM. Presentation Title: “Biomanufacturing: Moving Your Ideas from an Academic Lab Towards the Clinic” Dean will deliver a compelling 30-minute presentation on how to translate academic innovations into clinical applications\, offering invaluable insights for researchers\, innovators\, and clinicians in the regenerative medicine field. \nFeatured Speaker: \nDr. Tom Bollenbach\, ARMI’s Chief Technology Officer\, will present groundbreaking advancements in tissue engineering and biomanufacturing\, exploring the latest innovations driving the field forward. \nPre-Conference Workshop: \n\nTitle: “Innovation and Oversight: Navigating FDA Regulatory Pathways in Tissue Engineering”\nDate/Time: Sunday\, November 9\, 2025\, 1:00 PM – 4:00 PM\nOrganizer: Dr. Richard McFarland\, Chief Regulatory Officer\, ARMI\nDr. McFarland will lead a workshop focused on FDA regulatory pathways\, highlighting critical challenges and opportunities for tissue-engineered products. Accompanied by distinguished experts\, this session will offer actionable insights into risk-based policy\, quality management systems\, and the role of standards in advancing regenerative medicine.\n\nARMI’s participation underscores our commitment to fostering collaboration and advancing innovation in tissue engineering and regenerative medicine. Don’t miss this opportunity to connect with ARMI thought leaders and be part of meaningful conversations shaping the future of healthcare. \nFor more information about TERMIS-AM 2025 and ARMI’s involvement\, click here.
URL:https://www.armiusa.org/event/termis-am-2025/
LOCATION:Detriot\, MI\, Detroit\, MI\, United States
CATEGORIES:ARMI,BioFabUSA
ATTACH;FMTTYPE=image/png:https://www.armiusa.org/wp-content/uploads/2022/05/Featuredinperson-e1653358665154.png
END:VEVENT
END:VCALENDAR